RT @metabolomics: 2/2: Interest is high in improving quality control for clinical metabolomics: setting the path forward for community harm…
RT @metabolomics: 2/2: Interest is high in improving quality control for clinical metabolomics: setting the path forward for community harm…
RT @metabolomics: 2/2: Interest is high in improving quality control for clinical metabolomics: setting the path forward for community harm…
What about what is floating in literature already? Over the past 2 decades. m/z values, specifically or just #peaks. Can not/ should not cite them anymore? #metabolomics
RT @metabolomics: 2/2: Interest is high in improving quality control for clinical metabolomics: setting the path forward for community harm…
RT @metabolomics: 2/2: Interest is high in improving quality control for clinical metabolomics: setting the path forward for community harm…
RT @metabolomics: 2/2: Interest is high in improving quality control for clinical metabolomics: setting the path forward for community harm…
RT @metabolomics: 2/2: Interest is high in improving quality control for clinical metabolomics: setting the path forward for community harm…
RT @metabolomics: 2/2: Interest is high in improving quality control for clinical metabolomics: setting the path forward for community harm…
RT @metabolomics: 2/2: Interest is high in improving quality control for clinical metabolomics: setting the path forward for community harm…
2/2: Interest is high in improving quality control for clinical metabolomics: setting the path forward for community harmonization of quality control standards https://t.co/FuFzzw5Y7q https://t.co/zrE8nOUhw2
RT @realBioMassSpec: Interest is high in improving quality control for clinical metabolomics: setting the path forward for community harmon…
Interest is high in improving quality control for clinical metabolomics: setting the path forward for community harmonization of quality control standards #Metabolomics https://t.co/6hz4lPjNjg